Cannabics Pharmaceuticals' stock price, CNBX.US, is influenced by factors common to small-cap pharmaceutical companies, especially those in the cannabis space. Clinical Trial Results: Positive or negative data from clinical trials for Cannabics' drug candidates heavily impacts investor sentiment.

Regulatory Developments: Changes in cannabis regulations, particularly regarding medical cannabis research and availability, can significantly affect the stock.

Market Sentiment: Overall market sentiment towards the pharmaceutical and cannabis sectors influences trading volume and price.

Financial Performance: Cannabics' cash position, burn rate, and ability to secure funding affect investor confidence.

Competition: The emergence of competing drugs or therapies for Cannabics' target indications could negatively impact the stock.

News and Announcements: Company-specific announcements, like partnerships, acquisitions, or licensing agreements, influence price.

Investor Speculation: Given its small-cap nature, CNBX is susceptible to speculative trading and short-term price swings.